Fluoroestradiol (FES)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fluoroestradiol (FES), covering 2016-12-08 to 2016-12-08. Get the full timeline:
Most recent: Clinical Trial Update: Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer [Phase 3]